49 research outputs found

    EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness

    Get PDF
    The finding of novel molecular markers for prediction or prognosis of invasiveness in colorectal cancer (CRC) constitutes an appealing challenge. Here we show the up-regulation of EPDR1 in a prospective cohort of 101 CRC patients, in a cDNA array of 43 patients and in in silico analyses. EPDR1 encodes a protein related to ependymins, a family of glycoproteins involved in intercellular contacts. A thorough statistical model allowed us to conclude that the gene is significantly up-regulated in tumour tissues when compared with normal mucosa. These results agree with those obtained by the analysis of three publicly available databases. EPDR1 up-regulation correlates with the TNM staging parameters, especially T and M. Studies with CRC cell lines revealed that the methylation of a CpG island controls EPDR1 expression. siRNA knocking-down and overexpression of the gene following transient plasmid transfection, showed that EPDR1 favours cell proliferation, migration, invasiveness and adhesion to type I collagen fibres, suggesting a role in epithelial to mesenchymal transition. Both statistical and functional analysis correlated EPDR1 overexpression with invasiveness and dissemination of tumour cells, supporting the inclusion of EPDR1 in panels of genes used to improve molecular subtyping of CRC. Eventually, EPDR1 may be an actionable target.Fil: Gimeno Valiente, F.. No especifíca;Fil: Riffo Campos, Á. L.. Universidad de La Frontera; ChileFil: Ayala, G.. Universidad de Valencia; EspañaFil: Tarazona, N.. Universidad de Valencia; EspañaFil: Gambardella, V.. Universidad de Valencia; EspañaFil: Rodríguez, Fernanda Mariel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Ciencias Veterinarias del Litoral. Universidad Nacional del Litoral. Facultad de Ciencias Veterinarias. Instituto de Ciencias Veterinarias del Litoral; ArgentinaFil: Huerta, M.. Universidad de Valencia; EspañaFil: Martínez-Ciarpaglini, C.. Universidad de Valencia; EspañaFil: Montón Bueno, J.. Universidad de Valencia; EspañaFil: Roselló, S.. Universidad de Valencia; EspañaFil: Roda, D.. Universidad de Valencia; EspañaFil: Cervantes, A.. Universidad de Valencia; EspañaFil: Franco, L.. Universidad de Valencia; EspañaFil: López Rodas, G.. Universidad de Valencia; EspañaFil: Castillo, J.. Universidad de Valencia; Españ

    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

    Get PDF
    Purpose: To determine the frequency of breast cancer (BC) patients with hereditary risk features in a wide retrospective cohort of patients in Spain. Methods: a retrospective analysis was conducted from 10, 638 BC patients diagnosed between 1998 and 2001 in the GEICAM registry “El Álamo III”, dividing them into four groups according to modified ESMO and SEOM hereditary cancer risk criteria: Sporadic breast cancer group (R0); Individual risk group (IR); Familial risk group (FR); Individual and familial risk group (IFR) with both individual and familial risk criteria. Results: 7, 641 patients were evaluable. Of them, 2, 252 patients (29.5%) had at least one hereditary risk criteria, being subclassified in: FR 1.105 (14.5%), IR 970 (12.7%), IFR 177 (2.3%). There was a higher frequency of newly diagnosed metastatic patients in the IR group (5.1% vs 3.2%, p = 0.02). In contrast, in RO were lower proportion of big tumors (> T2) (43.8% vs 47.4%, p = 0.023), nodal involvement (43.4% vs 48.1%, p = 0.004) and lower histological grades (20.9% G3 for the R0 vs 29.8%) when compared to patients with any risk criteria. Conclusions: Almost three out of ten BC patients have at least one hereditary risk cancer feature that would warrant further genetic counseling. Patients with hereditary cancer risk seems to be diagnosed with worse prognosis factors

    Revalorization of Microalgae Biomass for Synergistic Interaction and Sustainable Applications: Bioplastic Generation

    Get PDF
    Microalgae and cyanobacteria are photosynthetic microorganisms' sources of renewable biomass that can be used for bioplastic production. These microorganisms have high growth rates, and contrary to other feedstocks, such as land crops, they do not require arable land. In addition, they can be used as feedstock for bioplastic production while not competing with food sources (e.g., corn, wheat, and soy protein). In this study, we review the macromolecules from microalgae and cyanobacteria that can serve for the production of bioplastics, including starch and glycogen, polyhydroxyalkanoates (PHAs), cellulose, polylactic acid (PLA), and triacylglycerols (TAGs). In addition, we focus on the cultivation of microalgae and cyanobacteria for wastewater treatment. This approach would allow reducing nutrient supply for biomass production while treating wastewater. Thus, the combination of wastewater treatment and the production of biomass that can serve as feedstock for bioplastic production is discussed. The comprehensive information provided in this communication would expand the scope of interdisciplinary and translational research.The authors would like to acknowledge the funding provided by Tecnologico de Monterrey through the Bioprocess Research Chair (0020209I13). This work was partially supported by Consejo Nacional de Ciencia y Tecnología (CONACyT), Mexico, under the Sistema Nacional de Investigadores (SNI) program awarded to Hafiz M. N. Iqbal (CVU: 735340) and Roberto Parra-Saldivar (CVU: 35753). The Technology Scholarship to Itzel Y. López-Pacheco (CVU: 859227), Laura Isabel Rodas-Zuluaga (CVU: 943350), and Enrique Hidalgo-Vázquez (CVU: 1095127) by CONACyT is also thankfully acknowledged. Additionally, the authors would like to acknowledge Juan Eduardo Sosa-Hernández for his support. The listed author(s) also want to thank and dedicate this work to “Abraham Molina-Vazquez” who was the great support from conceptualization to compilation of this work. However, much sadly, he is not among us anymore, may his soul rest in peace.Peer reviewe

    One Welfare for all: Associations between sheep welfare indicators and producers’ mental health

    Get PDF
    Objective. The objective of this observational cross-sectional study was to investigate associations between farmers’ mental health scores for stress, anxiety, depression, and resilience, and sheep welfare outcomes. Materials and methods. Twenty-two sheep farms in the departments of Boyacá, Cundinamarca, Tolima, and Meta, Colombia, were visited once. Clinical health, cleanliness, and calmness of randomly selected sheep per farm were scored to identify the number of animals with different welfare problems such as lameness, hoof overgrowth, and mastitis. A face-to-face interview with the farmer was done to gather demographic information (farm size and year of establishment, gender, age, role at the farm, and education) and to complete validated psychometric scales to assess resilience, stress, anxiety, and depression. Linear regression models were used to evaluate associations between farmers’ mental health scores, demographic aspects, and within-flock prevalence of sheep welfare indicators. Results. A total of 427 sheep were evaluated across farms. The most prevalent welfare problems identified were hoof overgrowth (40.9%) and dirty fleece (32.9%), while the least prevalent were clinical mastitis (1.3%) and respiratory issues (1.2%). Farmers’ stress level was positively associated with the prevalence of clinically lame sheep and farm size. Anxiety was positively associated with the prevalence of sheep with dirty fleece, clinical lameness, and with being a female farmer. Depression was positively associated with the prevalence of hoof overgrowth. Conclusions. Findings showed that higher levels of stress, anxiety, and depression among farmers were associated with the presence of animal welfare problems, larger farms, and gender

    Environmental persistence, detection, and mitigation of endocrine disrupting contaminants in wastewater treatment plants – a review with a focus on tertiary treatment technologies

    Get PDF
    Endocrine disrupting chemicals are a group of contaminants that have severe effects on humans and animals when exposed, like cancer and alterations to the nervous and reproductive systems. The increasing concentrations of several endocrine disrupting chemicals in the environment are strongly related to anthropogenic activities, and as the population grows this problem becomes more relevant. Thus, wastewater is one of the main sources of endocrine disrupting chemicals, and the technologies employed during primary and secondary treatment in wastewater treatment plants cannot remove these contaminants. Due to this, researchers have tried to develop more efficient technologies for tertiary treatment of wastewater and reduce the concentration of endocrine disrupting chemicals discharged into the environment. Some of the most promising technologies include adsorption, ultrafiltration, advanced oxidation processes and biodegradation. The use of nanomaterials as adsorbents, catalysts, membranes and supports has played a key role in enhancing the efficiency of these technologies. The results showed that these technologies have great potential on the lab-scale, and even some of them have already been employed at some wastewater treatment plants. However, there are still some challenges to achieving a global implementation of these technologies, related to reducing the costs of materials and enhancing their current performance. The use of biomass/waste derived carbon materials and implementing hybrid technologies are accessible approaches for their implementation in tertiary treatment.This work is part of the project entitled “Contaminantes emergentes y prioritarios en las aguas reutilizadas en agricultura: riesgos y efectos en suelos, producción agrícola y entorno ambiental” funded by CSIC-Tecnológico de Monterrey under the i-Link + program (LINKB20030). The author “Jesús Alfredo Rodríguez-Hernández” acknowledges Consejo Nacional de Ciencia y Tecnología (CONACyT) for awarding a scholarship for a PhD in nanotechnology (CVU: 924193). CONACyT is thankfully acknowledged for partially supporting this work under the Sistema Nacional de Investigadores (SNI) program awarded to Rafael G. Araújo (CVU: 714118), Juan Eduardo Sosa-Hernández (CVU: 375202), Elda M. Melchor-Martínez (CVU: 230784), Manuel Martinez-Ruiz (CVU: 418151), Hafiz M. N. Iqbal (CVU: 735340) and Roberto Parra-Saldívar (CVU: 35753). The authors are also thankful to “Programa Iberoamericano de Ciencia y Tecnología para el Desarrollo” in the Latin American development network “Lacasas Inmovilizadas para la Degradación de Compuestos Aromáticos en Aguas Residuales” (LIDA, project 318RT0552). All listed authors are also grateful to their representative universities/institutes for providing literature facilities and the Biorender online program for the elaboration of the graphical abstract and Fig. 1–5.Peer reviewe

    Solitary waves for linearly coupled nonlinear Schrodinger equations with inhomogeneous coefficients

    Full text link
    Motivated by the study of matter waves in Bose-Einstein condensates and coupled nonlinear optical systems, we study a system of two coupled nonlinear Schrodinger equations with inhomogeneous parameters, including a linear coupling. For that system we prove the existence of two different kinds of homoclinic solutions to the origin describing solitary waves of physical relevance. We use a Krasnoselskii fixed point theorem together with a suitable compactness criterion.Comment: 16 page

    Epigenetic Transcriptional Regulation of the Growth Arrest-Specific gene 1 (Gas1) in Hepatic Cell Proliferation at Mononucleosomal Resolution

    Get PDF
    BACKGROUND: Gas1 (growth arrest-specific 1) gene is known to inhibit cell proliferation in a variety of models, but its possible implication in regulating quiescence in adult tissues has not been examined to date. The knowledge of how Gas1 is regulated in quiescence may contribute to understand the deregulation occurring in neoplastic diseases. METHODOLOGY/PRINCIPAL FINDINGS: Gas1 expression has been studied in quiescent murine liver and during the naturally synchronized cell proliferation after partial hepatectomy. Chromatin immunoprecipitation at nucleosomal resolution (Nuc-ChIP) has been used to carry out the study preserving the in vivo conditions. Transcription has been assessed at real time by quantifying the presence of RNA polymerase II in coding regions (RNApol-ChIP). It has been found that Gas1 is expressed not only in quiescent liver but also at the cell cycle G(1)/S transition. The latter expression peak had not been previously reported. Two nucleosomes, flanking a nucleosome-free region, are positioned close to the transcription start site. Both nucleosomes slide in going from the active to the inactive state and vice versa. Nuc-ChIP analysis of the acquisition of histone epigenetic marks show distinctive features in both active states: H3K9ac and H3K4me2 are characteristic of transcription in G(0) and H4R3me2 in G(1)/S transition. Sequential-ChIP analysis revealed that the "repressing" mark H3K9me2 colocalize with several "activating" marks at nucleosome N-1 when Gas1 is actively transcribed suggesting a greater plasticity of epigenetic marks than proposed until now. The recruitment of chromatin-remodeling or modifying complexes also displayed distinct characteristics in quiescence and the G(1)/S transition. CONCLUSIONS/SIGNIFICANCE: The finding that Gas1 is transcribed at the G(1)/S transition suggests that the gene may exert a novel function during cell proliferation. Transcription of this gene is modulated by specific "activating" and "repressing" epigenetic marks, and by chromatin remodeling and histone modifying complexes recruitment, at specific nucleosomes in Gas1 promoter

    Guía de práctica clínica para la prevención, diagnóstico, tratamiento y rehabilitación de la falla cardiaca en población mayor de 18 años, clasificación B, C y D

    Get PDF
    La falla cardíaca es un síndrome clínico caracterizado por síntomas y signos típicos de insuficiencia cardíaca, adicional a la evidencia objetiva de una anomalía estructural o funcional del corazón. Guía completa 2016. Guía No. 53Población mayor de 18 añosN/
    corecore